Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.29 billion. The enterprise value is $5.40 billion.
| Market Cap | 5.29B |
| Enterprise Value | 5.40B |
Important Dates
The next estimated earnings date is Tuesday, October 20, 2026, before market open.
| Earnings Date | Oct 20, 2026 |
| Ex-Dividend Date | Dec 23, 2025 |
Share Statistics
Balchem has 31.88 million shares outstanding. The number of shares has decreased by -1.28% in one year.
| Current Share Class | 31.88M |
| Shares Outstanding | 31.88M |
| Shares Change (YoY) | -1.28% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 92.16% |
| Float | 31.69M |
Valuation Ratios
The trailing PE ratio is 32.68 and the forward PE ratio is 27.63. Balchem's PEG ratio is 2.91.
| PE Ratio | 32.68 |
| Forward PE | 27.63 |
| PS Ratio | 4.87 |
| Forward PS | 4.52 |
| PB Ratio | 4.07 |
| P/TBV Ratio | 15.48 |
| P/FCF Ratio | 30.89 |
| P/OCF Ratio | 24.10 |
| PEG Ratio | 2.91 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.03, with an EV/FCF ratio of 31.49.
| EV / Earnings | 32.82 |
| EV / Sales | 4.97 |
| EV / EBITDA | 20.03 |
| EV / EBIT | 24.34 |
| EV / FCF | 31.49 |
Financial Position
The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.66 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.61 |
| Debt / FCF | 0.97 |
| Interest Coverage | 25.54 |
Financial Efficiency
Return on equity (ROE) is 12.79% and return on invested capital (ROIC) is 12.25%.
| Return on Equity (ROE) | 12.79% |
| Return on Assets (ROA) | 8.24% |
| Return on Invested Capital (ROIC) | 12.25% |
| Return on Capital Employed (ROCE) | 14.39% |
| Weighted Average Cost of Capital (WACC) | 8.79% |
| Revenue Per Employee | $803,166 |
| Profits Per Employee | $121,608 |
| Employee Count | 1,352 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 4.47 |
Taxes
In the past 12 months, Balchem has paid $47.97 million in taxes.
| Income Tax | 47.97M |
| Effective Tax Rate | 22.59% |
Stock Price Statistics
The stock price has increased by +14.36% in the last 52 weeks. The beta is 0.85, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +14.36% |
| 50-Day Moving Average | 172.00 |
| 200-Day Moving Average | 168.07 |
| Relative Strength Index (RSI) | 43.23 |
| Average Volume (20 Days) | 194,580 |
Short Selling Information
The latest short interest is 620,041, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 620,041 |
| Short Previous Month | 554,840 |
| Short % of Shares Out | 1.95% |
| Short % of Float | 1.96% |
| Short Ratio (days to cover) | 3.55 |
Income Statement
In the last 12 months, Balchem had revenue of $1.09 billion and earned $164.41 million in profits. Earnings per share was $5.08.
| Revenue | 1.09B |
| Gross Profit | 394.12M |
| Operating Income | 221.72M |
| Pretax Income | 212.38M |
| Net Income | 164.41M |
| EBITDA | 269.41M |
| EBIT | 221.72M |
| Earnings Per Share (EPS) | $5.08 |
Balance Sheet
The company has $63.17 million in cash and $166.72 million in debt, with a net cash position of -$103.54 million or -$3.25 per share.
| Cash & Cash Equivalents | 63.17M |
| Total Debt | 166.72M |
| Net Cash | -103.54M |
| Net Cash Per Share | -$3.25 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 40.76 |
| Working Capital | 242.67M |
Cash Flow
In the last 12 months, operating cash flow was $219.62 million and capital expenditures -$48.26 million, giving a free cash flow of $171.36 million.
| Operating Cash Flow | 219.62M |
| Capital Expenditures | -48.26M |
| Depreciation & Amortization | 47.70M |
| Net Borrowing | -38.20M |
| Free Cash Flow | 171.36M |
| FCF Per Share | $5.38 |
Margins
Gross margin is 36.29%, with operating and profit margins of 20.42% and 15.14%.
| Gross Margin | 36.29% |
| Operating Margin | 20.42% |
| Pretax Margin | 19.56% |
| Profit Margin | 15.14% |
| EBITDA Margin | 24.81% |
| EBIT Margin | 20.42% |
| FCF Margin | 15.78% |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | 10.34% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 18.90% |
| FCF Payout Ratio | 17.86% |
| Buyback Yield | 1.28% |
| Shareholder Yield | 1.85% |
| Earnings Yield | 3.11% |
| FCF Yield | 3.24% |
Analyst Forecast
The average price target for Balchem is $209.25, which is 26.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $209.25 |
| Price Target Difference | 26.02% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 6.69% |
| EPS Growth Forecast (3Y) | 11.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 10.38 and a Piotroski F-Score of 8.
| Altman Z-Score | 10.38 |
| Piotroski F-Score | 8 |